Send Press Release To Your Friends

PR Title:	New Phase 3 Paid Meningitis Clinical Trial Now Enrolling at Avail Clinical Research near Orlando Florida; Accepting Male & Female Participants
PR Summary:	This study is a Phase 3, Randomized, Placebo-Controlled, Double-Blind Trial to Assess the Safety, Tolerability and Immunogenicity of a new Meningococcal Vaccine When Given in Healthy Subjects Age 11 to 26.

	Basic Information
	Your Name* Your Email* Friend's Name Friend's Email 1* 2   3   Your Message